Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1999
11/16/1999US5985935 Treatment and prophylaxis of diseases caused by parasites, or bacteria
11/16/1999US5985932 Inhibition of autoimmune diseases
11/16/1999US5985930 Treatment of neurodegenerative conditions with nimesulide
11/16/1999US5985928 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
11/16/1999US5985927 Medicaments for the selective treatment of tumor tissues
11/16/1999US5985926 Method for inhibiting intracellular viral replication
11/16/1999US5985924 Metastasis suppressory agents
11/16/1999US5985922 Amino acid derivatives and active oxygen-resisting agent
11/16/1999US5985920 Difluoroprostaglandin derivatives and their use
11/16/1999US5985918 Antiinflammatory agents
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985915 Cardiovascular disorders such as arrhythmia
11/16/1999US5985914 Treatment of inflammatory disorders of the bowel and urinary bladder
11/16/1999US5985913 Tetracyclic compounds for enhancing biosynthesis of erythropoietin, compositions containing same, and methods of use thereof
11/16/1999US5985909 Anticancer drugs used as prodrugs for antibody-directed enzyme-prodrug therapy (adept) and gene-directed enzyme-prodrug therapy (gdept) for cancer
11/16/1999US5985908 MCBI analogs of CC-1065 and the duocarmycins
11/16/1999US5985907 Method for inhibiting growth of methanogens
11/16/1999US5985906 Use of a combination of the squalene epoxidase inhibitor terbinafine and an azole 14-alpha-methyldemethylase inhibitor (fluconazole or itraconazole) in mycotic infections caused by azole-resistant fungal strains
11/16/1999US5985905 Useful for the treatment and/or prophylaxis of diseases associated with loss of bone mass, such as osteoporosis and related osteopenic diseases, paget's disease, hyperparathyroidism and related diseases, also antitumor
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985898 Inhibiting hyperlipidemia resulted from estrogen deficiency disease, reducing serum cholesterol,
11/16/1999US5985897 Benzothiphene compounds, intermediates, compositions, and methods
11/16/1999US5985896 Piperidine and morpholine derivatives and their use as therapeutic agents
11/16/1999US5985895 2-naphthamide derivatives and their therapeutic applications
11/16/1999US5985894 Useful in the treatment of cardiovascular illnesses
11/16/1999US5985893 Decreased hygroscopicity
11/16/1999US5985891 Use of virginiamycin to control the passage of carbohydrates into the gastrointestinal tract and the fermentation of these carbohydrates therein, controlling the accumulation of acid in the digestive tract
11/16/1999US5985890 Macrolide antibiotic having antitumor and antifungal activity
11/16/1999US5985889 Dosage forms and method for ameliorating male erectile dysfunction
11/16/1999US5985887 Aza-anthracyclinone derivatives
11/16/1999US5985886 Endothelin receptor antagonists
11/16/1999US5985885 Useful in the treatment of hypertension, congestive heart failure, prostate hypertrophy, various urinary tract disorders and pathological symptoms caused by hyperactivity or disfunctioning of the noradrenergic neural system
11/16/1999US5985881 Treatment and prevention of respiratory disorders, inflammatory eye diseases, inflammatory skin diseases, intestinal disorders, other inflammatory diseases
11/16/1999US5985880 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
11/16/1999US5985878 Angiogenesis inhibiting pyridazinamines
11/16/1999US5985877 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
11/16/1999US5985876 Antitumor agents
11/16/1999US5985873 Useful in the diagnosis and treatment of feeding disorders such as obesity and bulimia and cardiovascular diseases such as essential hypertension and congestive heart failure due to the binding of these compounds to human neuropeptide y1
11/16/1999US5985872 2-amino-benzoxazinones for the treatment of viral infections
11/16/1999US5985871 Benzoxazine compounds for enhancing synaptic response
11/16/1999US5985869 Benzoheterocyclic compounds
11/16/1999US5985868 Methods and compositions for treating androgen-dependant diseases using optically pure R-(-) casodex
11/16/1999US5985867 Treating hiv infection
11/16/1999US5985866 Use of serotonin antagonists for treating fibromyalgia
11/16/1999US5985865 Methods of increasing sphincter competence
11/16/1999US5985862 Treating undesired smooth muscle contractions and inflammatory diseases
11/16/1999US5985861 Progesterone for treating or reducing ischemia
11/16/1999US5985859 Methods of inhibiting bacterial sialidase
11/16/1999US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar
11/16/1999US5985856 Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
11/16/1999US5985855 Treatment of global and focal ischemia using NAALADase inhibitors
11/16/1999US5985854 Prodrugs with enhanced penetration into cells
11/16/1999US5985852 Composition for inhibiting binding between a first cell having a p- or l-selectin and a second cell having a ligand for the selectin, comprising a sheet of lipids
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985849 Phosphate compounds and their use as medicaments
11/16/1999US5985848 Inhibitors of nucleoside metabolism
11/16/1999US5985845 Methods for reducing mortality rates in poultry
11/16/1999US5985842 Formulations which provide good transdermal delivery, including appropriate solvent systems, microemulsions, liposomes
11/16/1999US5985826 Methods of using hepatic-directed compounds in pretargeting strategies
11/16/1999US5985662 By incubating hepatitis b virus or incubating cells, tissues, or a bodily fluid which contains hepatitis b virus with an antisense oligonucleotide of given nucleotide sequences under conditions where viral replication is inhibited
11/16/1999US5985625 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of Streptomyces sp. P 6621 FERM P 2804
11/16/1999US5985620 Polynucleotide
11/16/1999US5985600 Nucleic acid encoding delta opioid receptor
11/16/1999US5985592 Uses for pentoxifylline or functional derivatives/metabolites thereof
11/16/1999US5985589 Dna sequences
11/16/1999US5985583 Hybridization; measurement signal transduction
11/16/1999US5985335 Potassium citrate, malate or lactate; vitamin d, calcium salt and vitamin k; bone disorders, osteoporosis treatment; foods; dietetics
11/16/1999US5985331 Methods of use of phthalocyanines to inactivate blood borne parasites
11/16/1999US5985325 Tablet core with overcoating of sucrose, polyvinylpyrrolidone, and microcrystalline cellulose
11/16/1999US5985322 Enteric administering of pellet with fluoxetine core and hydroxypropylmethyl cellulose acetate succinate layer; side effect reduction
11/16/1999US5985321 Soft gelatin capsule manufacture
11/16/1999US5985320 Drug delivery; medical diagnosis; genetic engineering; administering agent that interacts with cell surface receptors
11/16/1999US5985319 Multi-phase compositions for an initial and delayed release of a vaginal medicament
11/16/1999US5985313 Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
11/16/1999US5985311 Estrogen, a gestagen or androgen, acrylate adhesive and, as resorption promoters, oleic acid and 2-(2-ethoxyethoxy)ethanol.
11/16/1999US5985309 Preparation of particles for inhalation
11/16/1999US5985296 Complexes of gamma-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use
11/16/1999US5985293 Antioxidative dermocosmetic compositions comprising very low dosages of melatonin/analogs
11/16/1999US5985292 Active phospholipids as a vector for active molecules
11/16/1999US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections
11/16/1999US5985286 Adenyl cyclase-hemolysin (ac-hly) protein,
11/16/1999US5985282 St. john's wort (hypercin) and mahuang (ephedra sinica or ephedrine)
11/16/1999US5985281 Antibody directed enzyme prodrug therapy (adept) using a non-naturally occuring mutant form of a host enzyme, especially a mutant form of ribonuclease.
11/16/1999US5985270 Antitumor
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999US5985259 Sustained release ophthalmic antibiotic compositions
11/16/1999US5985248 Preparing dry powders having hydrophobic and hydrophilic components
11/16/1999US5984887 Photopheresis treatment of leukocytes
11/16/1999US5983956 Formulation for inhalation
11/16/1999CA2169481C Method of inhibiting nitric oxide formation
11/16/1999CA2142848C Beads having a core coated with an antifungal and a polymer
11/16/1999CA2137811C Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/16/1999CA2120215C 2,3-dihydro-4(1h)-quinazolinones active in gastro-intestinal pathologies
11/16/1999CA2088761C Benzimidazole derivatives, process for their preparation and application
11/16/1999CA2088600C Herpes simplex virus vp16 vaccines
11/16/1999CA2078118C Cc-1065 analogs
11/16/1999CA2064815C Therapeutic heterocyclic compounds
11/16/1999CA2031746C Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
11/16/1999CA2013599C Aryl-substituted rhodanine derivatives